JP2024508808A5 - - Google Patents

Info

Publication number
JP2024508808A5
JP2024508808A5 JP2023551180A JP2023551180A JP2024508808A5 JP 2024508808 A5 JP2024508808 A5 JP 2024508808A5 JP 2023551180 A JP2023551180 A JP 2023551180A JP 2023551180 A JP2023551180 A JP 2023551180A JP 2024508808 A5 JP2024508808 A5 JP 2024508808A5
Authority
JP
Japan
Application number
JP2023551180A
Other languages
Japanese (ja)
Other versions
JPWO2022183101A5 (https=
JP2024508808A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/018117 external-priority patent/WO2022183101A1/en
Publication of JP2024508808A publication Critical patent/JP2024508808A/ja
Publication of JPWO2022183101A5 publication Critical patent/JPWO2022183101A5/ja
Publication of JP2024508808A5 publication Critical patent/JP2024508808A5/ja
Pending legal-status Critical Current

Links

JP2023551180A 2021-02-26 2022-02-28 抗muc1-c抗体及びcar-t構造 Pending JP2024508808A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163154618P 2021-02-26 2021-02-26
US63/154,618 2021-02-26
PCT/US2022/018117 WO2022183101A1 (en) 2021-02-26 2022-02-28 Anti-muc1-c antibodies and car-t structures

Publications (3)

Publication Number Publication Date
JP2024508808A JP2024508808A (ja) 2024-02-28
JPWO2022183101A5 JPWO2022183101A5 (https=) 2025-03-07
JP2024508808A5 true JP2024508808A5 (https=) 2025-03-07

Family

ID=80780549

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023551180A Pending JP2024508808A (ja) 2021-02-26 2022-02-28 抗muc1-c抗体及びcar-t構造

Country Status (9)

Country Link
US (1) US20240182597A1 (https=)
EP (1) EP4298129A1 (https=)
JP (1) JP2024508808A (https=)
KR (1) KR20230150825A (https=)
CN (1) CN116917327A (https=)
AU (1) AU2022226565A1 (https=)
CA (1) CA3211142A1 (https=)
MX (1) MX2023009882A (https=)
WO (1) WO2022183101A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL264941B2 (en) 2016-08-24 2025-12-01 Teneobio Inc Transgenic non-human animals producing modified heavy chain-only antibodies
NZ754713A (en) 2016-12-21 2025-11-28 Teneobio Inc Anti-bcma heavy chain-only antibodies
WO2019126756A1 (en) 2017-12-22 2019-06-27 Teneobio, Inc. Heavy chain antibodies binding to cd22
JP7776987B2 (ja) 2019-04-05 2025-11-27 テネオバイオ, インコーポレイテッド Psmaに結合する重鎖抗体
CN114206927B (zh) 2019-06-14 2025-03-21 特尼奥生物股份有限公司 与cd22和cd3结合的多特异性重链抗体
WO2025218621A1 (zh) * 2024-04-15 2025-10-23 原启生物科技(上海)有限责任公司 靶向muc1的抗原结合蛋白

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
EP1400536A1 (en) 1991-06-14 2004-03-24 Genentech Inc. Method for making humanized antibodies
US6096871A (en) 1995-04-14 2000-08-01 Genentech, Inc. Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life
JP4046354B2 (ja) 1996-03-18 2008-02-13 ボード オブ リージェンツ,ザ ユニバーシティ オブ テキサス システム 増大した半減期を有する免疫グロブリン様ドメイン
GB0115256D0 (en) 2001-06-21 2001-08-15 Babraham Inst Mouse light chain locus
WO2004042017A2 (en) 2002-10-31 2004-05-21 Genentech, Inc. Methods and compositions for increasing antibody production
CA2513113A1 (en) 2003-01-23 2004-08-05 Genentech, Inc. Methods for producing humanized antibodies and improving yield of antibodies or antigen binding fragments in cell culture
SI2311874T1 (sl) 2004-07-22 2017-12-29 Erasmus University Medical Center Rotterdam Department of Cell Biology and Genetics Vezavne molekule
US20160355591A1 (en) 2011-05-02 2016-12-08 Immunomedics, Inc. Subcutaneous anti-hla-dr monoclonal antibody for treatment of hematologic malignancies
US20100122358A1 (en) 2008-06-06 2010-05-13 Crescendo Biologics Limited H-Chain-only antibodies
EP2406284B9 (en) 2009-03-10 2017-03-01 Biogen MA Inc. Anti-bcma antibodies
GB0905023D0 (en) 2009-03-24 2009-05-06 Univ Erasmus Medical Ct Binding molecules
US9345661B2 (en) 2009-07-31 2016-05-24 Genentech, Inc. Subcutaneous anti-HER2 antibody formulations and uses thereof
US10059775B2 (en) * 2014-01-29 2018-08-28 Dana-Farber Cancer Institute, Inc. Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD)
CA3029209A1 (en) 2016-06-21 2017-12-28 Teneobio, Inc. Cd3 binding antibodies
MX2019000641A (es) * 2016-07-15 2019-06-10 Poseida Therapeutics Inc Composiciones de mucina1-receptor de antigeno quimerico y metodos para su uso.
IL264941B2 (en) 2016-08-24 2025-12-01 Teneobio Inc Transgenic non-human animals producing modified heavy chain-only antibodies
FI4050034T3 (fi) 2016-09-14 2024-06-10 Teneoone Inc Cd3:een sitoutuvia vasta-aineita
CA3162246A1 (en) * 2019-12-20 2021-06-24 Poseida Therapeutics, Inc. Anti-muc1 compositions and methods of use

Similar Documents

Publication Publication Date Title
JP2024508808A5 (https=)
CL2025004013A1 (es) Uso de una combinación herbicida que comprende una isoxazolina y un éter fenílico.
CL2025003023A1 (es) Motor hidráulico
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
BY13164U (https=)
BY13158U (https=)
CN307046390S (https=)
CN307045969S (https=)
CN307045391S (https=)
CN306840088S8 (https=)
BY13176U (https=)
BY13174U (https=)
BY13172U (https=)
BY13170U (https=)
BY13169U (https=)
BY13168U (https=)
BY13167U (https=)
BY13166U (https=)
BY13165U (https=)
CN307049313S (https=)